Two Sigma Advisers
ONCT

Two Sigma Advisers’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Two Sigma Advisers’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,180
Closed -$44.8K – 2712
2023
Q4 		$44.8K Sell
4,180
-740
-15% -$5.33K ﹤0.01% 2409
2023
Q3 		$29.5K Sell
4,920
-1,475
-23% -$10.4K ﹤0.01% 2309
2023
Q2 		$44.1K Sell
6,395
-90
-1% -$594 ﹤0.01% 2282
2023
Q1 		$102K Sell
6,485
-4,270
-40% -$84K ﹤0.01% 2381
2022
Q4 		$215K Sell
10,755
-4,005
-27% -$79.7K ﹤0.01% 2164
2022
Q3 		$263K Buy
14,760
+8,005
+119% +$172K ﹤0.01% 2105
2022
Q2 		$150K Buy
6,755
+1,980
+41% +$44.1K ﹤0.01% 2335
2022
Q1 		$133K Buy
4,775
+4,235
+784% +$154K ﹤0.01% 2453
2021
Q4 		$25K Sell
540
-5,690
-91% -$383K ﹤0.01% 2537
2021
Q3 		$520K Buy
6,230
+3,295
+112% +$273K ﹤0.01% 1912
2021
Q2 		$279K Buy
2,935
+755
+35% +$89.6K ﹤0.01% 2162
2021
Q1 		$363K Buy
+2,180
New +$288K ﹤0.01% 2150
2019
Q2 		– Sell
-381
Closed -$64K – 2480
2019
Q1 		$64K Buy
381
+55
+17% +$8.2K ﹤0.01% 2222
2018
Q4 		$36K Buy
+326
New +$65.2K ﹤0.01% 2295

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's ONCT Position: Q1 2024 in Review

Two Sigma Advisers sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2024, closing a stake of 4,180 shares — an estimated $44.8K sold.

Two Sigma Advisers first reported a position in ONCT in Q4 2018 and held it in 14 quarters. The position peaked at $520K in Q3 2021. 24 funds tracked by Wall St. Rank hold ONCT as of Q1 2024.

  • Two Sigma Advisers reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 4,180 Oncternal Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $44.8K.
  • Two Sigma Advisers first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2018 and held it in 14 quarters.
  • Two Sigma Advisers's Oncternal Therapeutics, Inc. Common Stock position peaked at $520K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.